(TBPH) Theravance Biopharma complete technical analysis [charts+indicators] | Buy/Sell Theravance Biopharma | (TBPH) share price targets
Complete technical analysis of Theravance Biopharma (TBPH) by charts plus indicators, forecast predictions and share price targets for Theravance Biopharma (TBPH)
Theravance Biopharma trades in USA in Health Care sector.
Showing technical analysis as on 2024-12-16 View latest technical analysis
10 day averaged volume of Theravance Biopharma is 210354
| Date | Daily Closing Price | Open | High | Low | Volume |
| 16 Mon Dec 2024 | 9.80 | 9.87 | 10.06 | 9.77 | 0.861 times |
| 13 Fri Dec 2024 | 9.88 | 9.84 | 10.00 | 9.74 | 1.05 times |
| 12 Thu Dec 2024 | 9.87 | 9.94 | 10.11 | 9.75 | 0.909 times |
| 11 Wed Dec 2024 | 10.04 | 10.08 | 10.10 | 9.95 | 0.616 times |
| 10 Tue Dec 2024 | 10.08 | 9.97 | 10.15 | 9.94 | 1.021 times |
| 09 Mon Dec 2024 | 9.96 | 9.89 | 10.25 | 9.89 | 0.657 times |
| 26 Tue Nov 2024 | 9.24 | 9.50 | 9.50 | 9.20 | 0.866 times |
| 26 Tue Nov 2024 | 9.24 | 9.50 | 9.50 | 9.20 | 0.866 times |
| 25 Mon Nov 2024 | 9.47 | 9.52 | 9.76 | 9.47 | 1.141 times |
| 22 Fri Nov 2024 | 9.47 | 9.59 | 9.75 | 9.37 | 1.618 times |
My analysis of stock is bullish for shortterm, but stock is in semi over bought zones and there are some chances of seeing a fall tomorrow. Use 9.9 as stoploss in an intra day sell trade for a target of 9.59. However, stock will show a bullish move above 9.9.
Share price targets for Theravance Biopharma (TBPH)
| Target Type | Value |
| Downside Target | 7.44 |
| Downside Target | 7.88 |
| Downside Target | 8.14 |
| Downside Target | 8.42 |
| Downside Target | 8.93 |
| Downside Target | 9.20 |
| Downside Target | 9.74 |
| Upside Target | 10.06 |
| Upside Target | 10.10 |
| Upside Target | 10.22 |
| Upside Target | 10.25 |
| Upside Target | 10.26 |
Intraday share price targets for Theravance Biopharma (TBPH)
| Target Type | Value |
| Downside Intraday Target | 9.69 |
| Downside Intraday Target | 9.59 |
| Upside Intraday Target | 9.98 |
| Upside Intraday Target | 10.17 |
| Upside Intraday Target | 9.88 |
Weekly technical analysis of Theravance Biopharma (TBPH)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 16 Mon Dec 2024 | 9.80 | 9.87 | 10.06 | 9.77 | 0.202 times |
| 13 Fri Dec 2024 | 9.88 | 9.89 | 10.25 | 9.74 | 4.91 times |
| 26 Tue Nov 2024 | 9.24 | 9.50 | 9.50 | 9.20 | 0.431 times |
| 26 Tue Nov 2024 | 9.24 | 9.52 | 9.76 | 9.20 | 0.288 times |
| 22 Fri Nov 2024 | 9.47 | 9.55 | 10.10 | 9.37 | 1.31 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Theravance Biopharma (TBPH)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 16 Mon Dec 2024 | 9.80 | 9.89 | 10.25 | 9.74 | 0.247 times |
| 26 Tue Nov 2024 | 9.24 | 8.46 | 10.26 | 8.14 | 1.24 times |
| 31 Thu Oct 2024 | 8.24 | 8.06 | 8.93 | 7.88 | 0.816 times |
| 30 Mon Sep 2024 | 8.06 | 8.18 | 8.42 | 7.88 | 0.378 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Theravance Biopharma (TBPH)
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Theravance Biopharma stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Theravance Biopharma in short term but the sell signal is initial and weak.
Theravance Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a buy signal for Theravance Biopharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Theravance Biopharma is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 9.68 and Theravance Biopharma (TBPH) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Theravance Biopharma (TBPH) stock. Volume based technical analysis of Theravance Biopharma (TBPH) stock is negative.
Theravance Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Theravance Biopharma stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Theravance Biopharma in short term but the sell signal is initial and weak.
Theravance Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a buy signal for Theravance Biopharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Theravance Biopharma is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 9.68 and Theravance Biopharma (TBPH) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Theravance Biopharma (TBPH) stock. Volume based technical analysis of Theravance Biopharma (TBPH) stock is negative.
Theravance Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.